No Data
No Data
Koneksa Announces Regeneron Joins Data Syndication Program for Parkinson's Digital Biomarkers Study
Regeneron Pharmaceuticals(REGN.US) Officer Sells US$6.85 Million in Common Stock
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
Form 144 | Regeneron Pharmaceuticals(REGN.US) Officer Proposes to Sell 6.85 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 28, $Regeneron Pharmaceuticals(REGN.US)$ Officer Christopher Fenimore intends to sell 5,680 shares of its common stock on Aug 28, with a total market value of
Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish?
Regeneron's Bispecific Antibody Obtains EC Nod for Lymphoma
104026079 : Good info, please post sector wise impacts on Fed Rate Cuts